Santos M,
Silveira K, Souza N, Costa D, Inaoka S. Extensive osteonecrosis of the maxilla
caused by bisphosphonates: Report of a rare case. J Clin Exp Dent.
2019;11(2):e203-7.
doi:10.4317/jced.55151
http://dx.doi.org/10.4317/jced.55151
___________________________________________________________________________________________________________
References
|
1.
Bermúdez-Bejarano EB, Serrera-Figallo MÁ, Gutiérrez-Corrales A, Romero-Ruiz
MM, Castillo-de-Oyagüe R, Gutiérrez-Pérez JL, et al. Analysis of different therapeutic protocols for osteonecrosis of the
jaw associated with oral and intravenous bisphosphonates. Med Oral Patol
Oral Cir Bucal. 2017;22: e43-57. |
|
|
|
|
|
2. Fliefel R, Tröltzsch M,
Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of
bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization
of patients: a systematic review. Int J Oral Maxillofac Surg. 2015;44:568-585. |
|
|
|
|
|
3. Ruggiero SL, Dodson TB,
Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of
Oral and Maxillofacial Surgeons: American Association of Oral and
Maxillofacial Surgeons position paper on medication-related osteonecrosis of
the jaw–2014 update. J
Oral Maxillofac Surg. 2014;72:1938. |
|
|
|
|
|
4. Ruggiero SL, Drew SJ.
Osteonecrosis od the jaw and bisphosphonates therapy. J Dent res.
2007;86:1013-1021. |
|
|
|
|
|
5. Fabbro MD, Gallesio G,
Mozzati M. Autologous platelet concentrates for bisphosphonate-related
osteonecrosis of the jaw treatment and prevention. A systematic review of the
literature. Eur J Cancer. 2015;1:62-74. |
|
|
|
|
|
6. Bashutski JD, Eber RM,
Kinney JS, Benavides E, Maitra S, Braun TM, et al. Teriparatide and osseous
regeneration in the oral cavity. N Engl J Med. 2010;363:2396-2405. |
|
|
|
|
|
7. Freiberger JJ,
Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, et al. What is
the role of hyperbaric oxygen in the management of bisphosphonate-related
osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen
as an adjunct to surgery and antibiotics J Oral Maxillofac Surg. 2012;70:1573-1583. |
|
|
|
|
|
8. Bagan L, Jiménez Y,
Leopoldo M, Murillo-Cortes J, Bagan J. Exposed necrotic bone in 183 patients
with bisphosphonate-related osteonecrosis of the jaw: Associated clinical
characteristics. Med
Oral Patol Oral Cir Bucal. 2017;22:e582-e585. |
|
|
|
|
|
9. Magremanne M, Reychler H.
Pentoxifylline and Tocopherol in the Treatment of Yearly Zoledronic
Acid–Related Osteonecrosis of the Jaw in a Corticosteroid-Induced
Osteoporosis. J
Oral Maxillofac Surg. 2014;72:334-337. |
|
|
|
|
|
10.
Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K, et al. Increased incidence of osteonecrosis of the jaw
after tooth extraction in patients treated with bisphosphonates: a cohort
study. Int J Oral Maxillofac Surg. 2012;41:1397-1403. |
|
|
|
|
|
11. Aljohani S, Fliefel R,
Ihbe J, Kühnisch J, Ehrenfeld M, Otto S. What is the effect of
anti-resorptive drugs (ARDs) on the development of medication-related
osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic
review. J
CranioMaxilloFac Surg. 2017;45:1493-1502. |
|
|
|
|
|
12. Otto S, Baumann S,
Ehrenfeld M, Pautke C. Successful surgical management of osteonecrosis of the
jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone
Resection. J
Craniomaxillofac Surg. 2013;41:694-698. |
|
|
|
|
|
13. Daif ET. Long-Term
Effectiveness of the Pedicled Buccal Fat Pad in the Closure of a Large
Oroantral Fistula. J
Oral Maxillofac Surg. 2016;74:1718-1722. |
|
|
|
|
|
14. Gavin Clavero MA, Simón
Sanz MV, Jariod Ferrer UM, Mur Til A. Versatility of buccinator flaps for the
treatment of palatal defects: a series of cases. Br J Oral Maxillofac Surg.
2017;55:357-362. |
|
|
|
|
|
15. Delanian S, Chatel C,
Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory
mandibular osteoradionecrosis by prolonged treatment with a
pentoxifylline-tocopherol-clodronate combination (PENTOCLO): A phase II
trial. Int J Radiat Oncol Biol Phys. 2011;80:832-839. |
|